Michigan Center for Diabetes Translational Research (MCDTR)
William H. Herman
John D. Piette, Ph.D.
The MCDTR is a multidisciplinary unit of the University of Michigan, one of seven centers funded by the National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health to focus on type 2 translational research in diabetes (e.g., bedside to practice and the community). William H. Herman, M.D., M.P.H., is director of the Center. Dr. Herman is a Professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes, Professor of Epidemiology, and the Stefan S. Fajans / GlaxoSmithKline Professor of Diabetes. John D. Piette, Ph.D., Professor of Internal Medicine, is Associate Director.
The goal of the MCDTR is to facilitate innovative adaptations of evidence-based approaches to prevent and treat diabetes that can be disseminated and sustained in clinical practice and in settings outside the traditional academic research environment. The mission of the MCDTR is to establish, promote, and enhance multidisciplinary collaboration among researchers directed at the prevention and control of diabetes, its complications, and comorbidities, by providing access to specialized expertise and resources. Our research investigators are our most important resource.
The MCDTR focuses on research to better translate interventions that have clearly demonstrated efficacy into real-world populations, health care settings, and communities. The center helps to ensure that new research findings actually reach the patients and populations for whom they are intended, and that they are implemented correctly.
The MCDTR seeks to improve the quality of care by helping patients and clinicians alter behaviors and make more informed choices. By empowering the patient, strengthening the patient-clinician relationship, providing reminders and point-of-care decision support tools, and reorganizing and coordinating systems of care, more effective prevention and treatment of diabetes can be achieved.
The specific aims of the MCDTR are to:
- Raise awareness of, and interest in, type 2 translational research in diabetes and related conditions and create an environment that supports such research
- Identify, develop, and support researchers engaged in research to translate interventions with proven efficacy into real world health care settings, communities, and populations at risk
- Administer cores that provide services critical to type 2 translational research in diabetes for new and established investigators
- Foster interdisciplinary collaborations to advance type 2 translational research in diabetes
- Provide education and training opportunities in diabetes translational research
- Administer a Pilot and Feasibility Study Grants Program to attract new investigators and enable them to generate preliminary data for successful grant applications
MDRC/MCDTR Research Grants
The specific aim of the grants programs is to stimulate new research at the University of Michigan and regionally in the areas of diabetes, its complications, and related endocrine and metabolic disorders.
Research may be in areas of basic biomedical science, behavioral, clinical, epidemiologic or health services research — or in areas related to the development of methodologies for training patients and health care professionals.
For more information, visit the
Michigan Center for Diabetes Translational Research website: